Yes. Our GMP facility has been designed with commercial readiness in mind, including dedicated expansion space for large-scale vector, RNA, or cell therapy production. Our systems, quality oversight, and digital batch records meet the demands of global regulatory agencies, and our team brings experience from leading commercial manufacturing programmes.
Apr 11, 2025
Can we support commercial manufacturing?
Yes. Our GMP facility has been designed with commercial readiness in mind, including dedicated expansion space for large-scale vector, RNA, or cell therapy production. Our systems, quality oversight, and digital batch records meet the demands of global regulatory agencies, and our team brings experience from leading commercial manufacturing programmes.
Latest News
eXmoor Pharma and Signadori Bio launch partnership to develop next-generation monocyte-based cell therapy for solid tumours
Jun 17, 2025
Scaling Gene Therapy Production: From Bench to Clinic
May 30, 2025
eXmoor Pharma and KU Leuven announce strategic partnership to accelerate cell and gene therapy innovation through new venture
May 13, 2025
Let’s Accelerate Your Therapy Together
Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.